{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:03:11Z","timestamp":1789549391842,"version":"build-2803163510"},"reference-count":156,"publisher":"Elsevier","isbn-type":[{"value":"9780443432385","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acr.2026.06.002","type":"book-chapter","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:12:20Z","timestamp":1788174740000},"page":"97-162","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-associated macrophages: Ontogeny, plasticity, spatial ecosystems, and therapeutic targeting"],"prefix":"10.1016","author":[{"given":"Atif","family":"Elnaggar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Elnaggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"385","key":"10.1016\/bs.acr.2026.06.002_bib0001","doi-asserted-by":"crossref","first-page":"eaak9679","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"11","key":"10.1016\/bs.acr.2026.06.002_bib0002","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nature Reviews Cancer"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0003","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2018.04.007","article-title":"A unidirectional transition from migratory to perivascular macrophage is required for tumor cell intravasation","volume":"23","author":"Arwert","year":"2018","journal-title":"Cell Reports"},{"issue":"5838","key":"10.1016\/bs.acr.2026.06.002_bib0004","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"issue":"7765","key":"10.1016\/bs.acr.2026.06.002_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-1311-3","article-title":"Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function","volume":"571","author":"Bailis","year":"2019","journal-title":"Nature"},{"issue":"7769","key":"10.1016\/bs.acr.2026.06.002_bib0006","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0007","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nature Reviews Cancer"},{"issue":"6024","key":"10.1016\/bs.acr.2026.06.002_bib0008","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"issue":"7813","key":"10.1016\/bs.acr.2026.06.002_bib0009","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41586-020-2316-7","article-title":"Deciphering human macrophage development at single-cell resolution","volume":"582","author":"Bian","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nature Medicine"},{"issue":"10","key":"10.1016\/bs.acr.2026.06.002_bib0011","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nature Immunology"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0012","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ccell.2024.04.002","article-title":"A temporal perspective for tumor-associated macrophage identities and functions","volume":"42","author":"Bl\u00e9riot","year":"2024","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/bs.acr.2026.06.002_bib0013","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","article-title":"Nerve dependence: From regeneration to cancer","volume":"31","author":"Boilly","year":"2017","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0014","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","article-title":"Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies","volume":"17","author":"Bowman","year":"2016","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume":"19","author":"Bruchard","year":"2013","journal-title":"Nature Medicine"},{"issue":"7791","key":"10.1016\/bs.acr.2026.06.002_bib0017","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0018","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0019","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/bs.acr.2026.06.002_bib0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: Therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0021","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1016\/j.cub.2020.01.031","article-title":"Tumor-associated macrophages","volume":"30","author":"Cassetta","year":"2020","journal-title":"Current Biology"},{"issue":"3","key":"10.1016\/bs.acr.2026.06.002_bib0022","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2025.02.009","article-title":"Single-cell multi-stage spatial evolutional map of esophageal carcinogenesis","volume":"43","author":"Chang","year":"2025","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/bs.acr.2026.06.002_bib0023","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1073\/pnas.1815515116","article-title":"Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer","volume":"116","author":"Chen","year":"2019","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0024","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: An accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"Journal of Biomedical Science"},{"issue":"7519","key":"10.1016\/bs.acr.2026.06.002_bib0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0026","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0027","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"10.1016\/bs.acr.2026.06.002_bib0028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies","volume":"23","author":"De Palma","year":"2013","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/bs.acr.2026.06.002_bib0029","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discovery"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0031","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrc.2016.54","article-title":"The role of myeloid cells in cancer therapies","volume":"16","author":"Engblom","year":"2016","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0032","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunology Research"},{"issue":"11","key":"10.1016\/bs.acr.2026.06.002_bib0033","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.3390\/ijms25116082","article-title":"Tumor-derived exosomal miR-143-3p induces macrophage M2 polarization to cause radiation resistance in locally advanced esophageal squamous cell carcinoma","volume":"25","author":"Gao","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0035","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0037","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"issue":"13","key":"10.1016\/bs.acr.2026.06.002_bib0038","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2011-08-376426","article-title":"Recruitment of monocytes\/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice","volume":"119","author":"Gil-Bernab\u00e9","year":"2012","journal-title":"Blood"},{"issue":"6005","key":"10.1016\/bs.acr.2026.06.002_bib0039","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.acr.2026.06.002_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","article-title":"Tissue-resident macrophage ontogeny and homeostasis","volume":"44","author":"Ginhoux","year":"2016","journal-title":"Immunity"},{"issue":"7655","key":"10.1016\/bs.acr.2026.06.002_bib0041","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"issue":"6344","key":"10.1016\/bs.acr.2026.06.002_bib0042","doi-asserted-by":"crossref","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","article-title":"An environment-dependent transcriptional network specifies human microglia identity","volume":"356","author":"Gosselin","year":"2017","journal-title":"Science"},{"issue":"23","key":"10.1016\/bs.acr.2026.06.002_bib0043","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1158\/1078-0432.CCR-09-2399","article-title":"Targeting histone demethylases in cancer therapy","volume":"15","author":"Grant","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10.1016\/bs.acr.2026.06.002_bib0044","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20131199","article-title":"Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF","volume":"210","author":"Guilliams","year":"2013","journal-title":"Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0046","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nri.2017.42","article-title":"Does niche competition determine the origin of tissue-resident macrophages?","volume":"17","author":"Guilliams","year":"2017","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0047","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discovery"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0048","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1158\/2159-8290.CD-15-0012","article-title":"Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA","volume":"5","author":"Harney","year":"2015","journal-title":"Cancer Discovery"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0049","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","article-title":"Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes","volume":"38","author":"Hashimoto","year":"2013","journal-title":"Immunity"},{"issue":"7595","key":"10.1016\/bs.acr.2026.06.002_bib0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature16985","article-title":"Visualization of immediate immune responses to pioneer metastatic cells in the lung","volume":"531","author":"Headley","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0051","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2015.03.011","article-title":"C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages","volume":"42","author":"Hoeffel","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/bs.acr.2026.06.002_bib0052","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fimmu.2015.00486","article-title":"Ontogeny of tissue-resident macrophages","volume":"6","author":"Hoeffel","year":"2015","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0053","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/bies.200800189","article-title":"Reprogramming cell fates: Reconciling rarity with robustness","volume":"31","author":"Huang","year":"2009","journal-title":"Bioessays"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0054","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ni.2956","article-title":"Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages","volume":"15","author":"Huang","year":"2014","journal-title":"Nature Immunology"},{"issue":"4 Suppl 3","key":"10.1016\/bs.acr.2026.06.002_bib0055","first-page":"7","article-title":"Antiangiogenic therapy for cancer: Current and emerging concepts","volume":"19","author":"Jain","year":"2005","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/bs.acr.2026.06.002_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1573039","article-title":"Lactate-mediated metabolic reprogramming of tumor-associated macrophages: Implications for tumor progression and therapeutic potential","volume":"16","author":"Jin","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"7779","key":"10.1016\/bs.acr.2026.06.002_bib0057","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1674-5","article-title":"VISTA is an acidic pH-selective ligand for PSGL-1","volume":"574","author":"Johnston","year":"2019","journal-title":"Nature"},{"issue":"6230","key":"10.1016\/bs.acr.2026.06.002_bib0058","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0059","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","article-title":"Influence of metabolism on epigenetics and disease","volume":"153","author":"Kaelin","year":"2013","journal-title":"Cell"},{"issue":"7629","key":"10.1016\/bs.acr.2026.06.002_bib0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature19834","article-title":"PI3K\u03b3 is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003326","article-title":"Unveiling cancer crosstalk: Mapping complexity across time and space","volume":"23","author":"Kang","year":"2025","journal-title":"PLoS Biology"},{"issue":"7948","key":"10.1016\/bs.acr.2026.06.002_bib0062","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/bs.acr.2026.06.002_bib0063","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0064","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0065","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discovery"},{"issue":"3","key":"10.1016\/bs.acr.2026.06.002_bib0066","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/SHK.0000000000002746","article-title":"Chromatin remodeling and transcriptional silencing define the dynamic innate immune response of tissue resident macrophages after burn injury","volume":"65","author":"Kim","year":"2025","journal-title":"Shock"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0067","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nature Biotechnology"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0068","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/bs.acr.2026.06.002_bib0069","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fimmu.2014.00489","article-title":"Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression","volume":"5","author":"Laoui","year":"2014","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0070","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cell.2014.11.018","article-title":"Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment","volume":"159","author":"Lavin","year":"2014","journal-title":"Cell"},{"issue":"11","key":"10.1016\/bs.acr.2026.06.002_bib0071","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nri3088","article-title":"Transcriptional regulation of macrophage polarization: Enabling diversity with identity","volume":"11","author":"Lawrence","year":"2011","journal-title":"Nature Reviews Immunology"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0072","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","article-title":"Spatial omics and multiplexed imaging to explore cancer biology","volume":"18","author":"Lewis","year":"2021","journal-title":"Nature Methods"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0073","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1016\/j.apsb.2025.07.021","article-title":"Understanding the complexity of tumor-associated macrophages: Druggable and therapeutic insights","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0074","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.immuni.2024.05.008","article-title":"Collaboration between distinct SWI\/SNF chromatin remodeling complexes directs enhancer selection and activation of macrophage inflammatory genes","volume":"57","author":"Liao","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/bs.acr.2026.06.002_bib0075","article-title":"Macrophages and metabolic reprograming in the tumor microenvironment","volume":"12","author":"Liu","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0076","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ni.3796","article-title":"\u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming","volume":"18","author":"Liu","year":"2017","journal-title":"Nature Immunology"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0077","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 immune checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/bs.acr.2026.06.002_bib0078","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1084\/jem.20180534","article-title":"Macrophages of distinct origins contribute to tumor development in the lung","volume":"215","author":"Loyher","year":"2018","journal-title":"Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0079","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.cell.2019.01.022","article-title":"Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics","volume":"176","author":"Ludwig","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends in Immunology"},{"issue":"6142","key":"10.1016\/bs.acr.2026.06.002_bib0081","doi-asserted-by":"crossref","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0082","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0083","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1152\/ajpendo.00362.2014","article-title":"Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation","volume":"308","author":"Malandrino","year":"2015","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"11","key":"10.1016\/bs.acr.2026.06.002_bib0084","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nature Reviews Drug Discovery"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0086","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nature Communications"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0087","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/2159-8290.CD-23-1300","article-title":"Spatially segregated macrophage populations predict distinct outcomes in colon cancer","volume":"14","author":"Matusiak","year":"2024","journal-title":"Cancer Discovery"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0088","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ccr.2011.02.005","article-title":"Targeting the ANG2\/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells","volume":"19","author":"Mazzieri","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acr.2026.06.002_bib0089","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-017-0358-y","article-title":"Epi-drugs in combination with immunotherapy: A new avenue to improve anticancer efficacy","volume":"9","author":"Mazzone","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"49","key":"10.1016\/bs.acr.2026.06.002_bib0090","doi-asserted-by":"crossref","first-page":"eabb8471","DOI":"10.1126\/sciadv.abb8471","article-title":"YAP-mediated mechanotransduction tunes the macrophage inflammatory response","volume":"6","author":"Meli","year":"2020","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0091","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41590-018-0255-3","article-title":"Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation","volume":"20","author":"Minhas","year":"2019","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccell.2025.10.007","article-title":"Decoding the spatial dynamics of tumor and immune cell interactions in solid cancers","volume":"44","author":"Minogue","year":"2026","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0093","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13073-023-01197-0","article-title":"Mechanistic insights into the interactions between cancer drivers and the tumour immune microenvironment","volume":"15","author":"Misetic","year":"2023","journal-title":"Genome Medicine"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0094","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","article-title":"Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease","volume":"54","author":"Mulder","year":"2021","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/bs.acr.2026.06.002_bib0095","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bbalip.2016.09.002","article-title":"Macrophage fatty acid oxidation and its roles in macrophage polarization and fatty acid-induced inflammation","volume":"1861","author":"Namgaladze","year":"2016","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"12","key":"10.1016\/bs.acr.2026.06.002_bib0096","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","article-title":"Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies","volume":"44","author":"Nasir","year":"2023","journal-title":"Trends in Immunology"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0097","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41590-019-0399-9","article-title":"Adaptation and memory in immune responses","volume":"20","author":"Natoli","year":"2019","journal-title":"Nature Immunology"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0098","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0099","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: From mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: A single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0101","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cell.2014.04.016","article-title":"Tissue-specific signals control reversible program of localization and functional polarization of macrophages","volume":"157","author":"Okabe","year":"2014","journal-title":"Cell"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0102","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0103","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41467-020-14433-7","article-title":"Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase","volume":"11","author":"Palmieri","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/bs.acr.2026.06.002_bib0104","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fimmu.2020.00784","article-title":"The tumor microenvironment in the response to immune checkpoint blockade therapies","volume":"11","author":"Petitprez","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: A strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochimica et Biophysica Acta\u2014Reviews on Cancer"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0106","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/bs.acr.2026.06.002_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108111","article-title":"The immune modifying effects of chemotherapy and advances in chemo-immunotherapy","volume":"236","author":"Principe","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"issue":"10","key":"10.1016\/bs.acr.2026.06.002_bib0108","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nature Medicine"},{"issue":"7355","key":"10.1016\/bs.acr.2026.06.002_bib0109","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0111","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","article-title":"Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy","volume":"25","author":"Ries","year":"2014","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0112","doi-asserted-by":"crossref","first-page":"dju136","DOI":"10.1093\/jnci\/dju136","article-title":"Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer","volume":"106","author":"Rohan","year":"2014","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0113","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"6204","key":"10.1016\/bs.acr.2026.06.002_bib0114","doi-asserted-by":"crossref","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"issue":"12","key":"10.1016\/bs.acr.2026.06.002_bib0115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.tins.2016.10.002","article-title":"Can stopping nerves, stop cancer?","volume":"39","author":"Saloman","year":"2016","journal-title":"Trends in Neuroscience"},{"issue":"13","key":"10.1016\/bs.acr.2026.06.002_bib0116","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"12","key":"10.1016\/bs.acr.2026.06.002_bib0117","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1182\/blood-2008-01-136895","article-title":"Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice","volume":"111","author":"Sawanobori","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/bs.acr.2026.06.002_bib0118","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cell.2020.10.021","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"183","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/bs.acr.2026.06.002_bib0119","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nature Reviews Cancer"},{"issue":"7550","key":"10.1016\/bs.acr.2026.06.002_bib0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0121","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","article-title":"Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells","volume":"25","author":"Shojaei","year":"2007","journal-title":"Nature Biotechnology"},{"issue":"23","key":"10.1016\/bs.acr.2026.06.002_bib0122","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.180331.111","article-title":"Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer","volume":"25","author":"Shree","year":"2011","journal-title":"Genes & Development"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0123","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41422-020-0379-5","article-title":"Metabolic signaling in T cells","volume":"30","author":"Shyer","year":"2020","journal-title":"Cell Research"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0124","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nature Reviews Genetics"},{"issue":"7","key":"10.1016\/bs.acr.2026.06.002_bib0125","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0126","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/ATVBAHA.120.314037","article-title":"Metabolic reprogramming in immune response and tissue inflammation","volume":"40","author":"Sun","year":"2020","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"7444","key":"10.1016\/bs.acr.2026.06.002_bib0127","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0128","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1411366","article-title":"Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor","volume":"373","author":"Tap","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0129","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","article-title":"CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0130","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.7150\/jca.84632","article-title":"Tumor cell-derived extracellular vesicles in modulating phenotypes and immune functions of macrophages: Mechanisms and therapeutic applications","volume":"14","author":"Tian","year":"2023","journal-title":"Journal of Cancer"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0131","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","article-title":"Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer","volume":"171","author":"Topper","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41571-019-0266-5","article-title":"The emerging role of epigenetic therapeutics in immuno-oncology","volume":"17","author":"Topper","year":"2020","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0133","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.immuni.2024.04.019","article-title":"Classical monocyte ontogeny dictates their functions and fates as tissue macrophages","volume":"57","author":"Trzebanski","year":"2024","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0134","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","article-title":"Macrophage immunometabolism: Where are we (going)?","volume":"38","author":"Van den Bossche","year":"2017","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.acr.2026.06.002_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-60327-360-2_13","article-title":"Liposomes for specific depletion of macrophages from organs and tissues","volume":"605","author":"van Rooijen","year":"2010","journal-title":"Methods in Molecular Biology"},{"issue":"8","key":"10.1016\/bs.acr.2026.06.002_bib0136","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/bs.acr.2026.06.002_bib0137","article-title":"Tumor-derived extracellular vesicles regulate macrophage polarization: Role and therapeutic perspectives","volume":"15","author":"Wang","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0138","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precision Oncology"},{"issue":"6","key":"10.1016\/bs.acr.2026.06.002_bib0139","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: A fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/bs.acr.2026.06.002_bib0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejca.2017.02.013","article-title":"Cancer immunotherapy targeting the CD47\/SIRP\u03b1 axis","volume":"76","author":"Weiskopf","year":"2017","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0141","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nmat3780","article-title":"Imaging macrophages with nanoparticles","volume":"13","author":"Weissleder","year":"2014","journal-title":"Nature Materials"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0142","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/bs.acr.2026.06.002_bib0143","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.acr.2026.06.002_bib0144","article-title":"Lactate and lactylation in macrophage metabolic reprogramming: Current progress and outstanding issues","volume":"15","author":"Xu","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0146","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/ijo.2022.5347","article-title":"Role of macrophages in tumor progression and therapy (Review)","volume":"60","author":"Xu","year":"2022","journal-title":"International Journal of Oncology"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0147","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/bs.acr.2026.06.002_bib0148","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41419-024-06616-7","article-title":"Advances in engineered macrophages: A new frontier in cancer immunotherapy","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0149","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/bs.acr.2026.06.002_bib0150","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: New and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2026.06.002_bib0151","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.acr.2026.06.002_bib0152","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","article-title":"Nerves in cancer","volume":"20","author":"Zahalka","year":"2020","journal-title":"Nature Reviews Cancer"},{"issue":"11","key":"10.1016\/bs.acr.2026.06.002_bib0153","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nature Nanotechnology"},{"issue":"7779","key":"10.1016\/bs.acr.2026.06.002_bib0154","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.acr.2026.06.002_bib0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","article-title":"Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/bs.acr.2026.06.002_bib0156","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"}],"container-title":["Advances in Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:07:09Z","timestamp":1789546029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X26000680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443432385"],"references-count":156,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2026.06.002","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}